Page last updated: 2024-10-30

mecamylamine and Peritonitis

mecamylamine has been researched along with Peritonitis in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silva, RL1
Castanheira, FV1
Figueiredo, JG1
Bassi, GS1
Ferreira, SH1
Cunha, FQ1
Cunha, TM1
Kanashiro, A1

Other Studies

1 other study available for mecamylamine and Peritonitis

ArticleYear
Pharmacological Beta-Adrenergic Receptor Activation Attenuates Neutrophil Recruitment by a Mechanism Dependent on Nicotinic Receptor and the Spleen.
    Inflammation, 2016, Volume: 39, Issue:4

    Topics: Adrenergic beta-Agonists; Animals; Chemotaxis, Leukocyte; Cytokines; Isoproterenol; Mecamylamine; Mi

2016